Virology News and Research

Latest Virology News and Research

NSAIDs dampen antibody and inflammatory responses to SARS-CoV-2 infection in mice

New research shows that non-steroidal anti-inflammatory drugs (NSAIDs) reduced both antibody and inflammatory responses to SARS-CoV-2 infection in mice. The study appears this week in the Journal of Virology, a publication of the American Society for Microbiology.

22 Jan 2021

Patients fend for themselves to access highly touted covid antibody treatments

By the time he tested positive for covid-19 on Jan. 12, Gary Herritz was feeling pretty sick. He suspects he was infected a week earlier, during a medical appointment in which he saw health workers who were wearing masks beneath their noses or who had removed them entirely.

20 Jan 2021

New multidisciplinary center to study origin and course of infectious diseases

The University of Bern is establishing a multidisciplinary center to study the origin and course of infectious diseases and their impact on health, society and economics. The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years.

20 Jan 2021

On Trump’s last full day, nation records 400,000 covid deaths

While millions wait for a lifesaving shot, the U.S. death count from covid-19 continues to soar upward with horrifying speed.

19 Jan 2021

National consortium to study the effects of emerging SARS-CoV-2 mutations

A new national research project to study the effects of emerging mutations in SARS-CoV-2 will be launched with £2.5 million of funding from UK Research and Innovation.

15 Jan 2021

Patient with hypertension or cardiovascular diseases experienced critical disease progression with COVID-19

COVID-19 patients who also suffer from high blood pressure are more likely to fall severely ill with the disease, which also leaves them at greater risk of death.

11 Jan 2021

Advanced nanomaterial-based biosensing platform rapidly detects COVID-19 antibodies

Researchers at Carnegie Mellon University report findings on an advanced nanomaterial-based biosensing platform that detects, within seconds, antibodies specific to SARS-CoV-2, the virus responsible for the COVID-19 pandemic.

8 Jan 2021

Researchers demonstrate lab tool that simplifies simulations of the human intestine

Rice University and Baylor College of Medicine researchers have found a way to mimic conditions in intestines, giving them a mechanical model for the real-time growth of bacterial infections.

8 Jan 2021

Scientific experts help fight the spread of misinformation about COVID-19 vaccines

A team of renowned scientific experts has joined forces from across the world to help fight the spread of misinformation about the COVID-19 vaccines, which hold the key to beating the deadly pandemic and releasing countries from debilitating lockdown restrictions.

7 Jan 2021

Reston virus causes severe respiratory disease in piglets

Reston ebolavirus (RESTV) should be considered a livestock pathogen with potential to affect other mammals, including people, according to National Institutes of Health scientists.

21 Dec 2020

Scientists map direct interactions between SARS-CoV-2 RNA and human host cells

Scientists from Würzburg and the US have charted the first global atlas of direct interactions between SARS-CoV-2 RNA and human host cells. This may provide a starting point for novel treatments.

21 Dec 2020

AOAC INTERNATIONAL issues Certificates of Validation for three test kits that detect SARS-CoV-2

AOAC INTERNATIONAL announced today that it has issued Certificates of Validation for three proprietary test kits that detect SARS-CoV-2, the causative agent of COVID-19 illness, on environmental surfaces.

18 Dec 2020

Novel SARS-CoV-2 neutralizing antibody enters Phase 1/2a clinical study

Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer Ingelheim today announced the initiation of Phase 1/2a clinical investigation of BI 767551, a new SARS-CoV-2 neutralizing antibody.

18 Dec 2020

Cell atlas helps better understand the biology of tropical disease parasite

The first cell atlas of an important life stage of Schistosoma mansoni, a parasitic worm that poses a risk to hundreds of millions of people each year, has been developed by researchers at the Wellcome Sanger Institute and their collaborators.

18 Dec 2020

University of Ottawa earns 10 Canada research chairs covering a broad scope of subjects

The University of Ottawa has earned a total of 10 Canada Research Chairs (CRCs) covering a broad scope of subjects, from the exploration of disruptive impacts of stress on higher brain functions to the need to preserve Indigenous traditional cultural memories, and emerging computing technologies that pave the way to smart cities.

18 Dec 2020

$3.7 million NIH grant supports development of biosensor technology for diagnosing viral diseases

For over ten years, Ali Yanik has been working to develop novel biosensor technology to provide rapid, low-cost testing for disease diagnostics and precision medicine.

16 Dec 2020

SARS-CoV-2 unique deletion variants found in clinical specimens

While participating in the SPHERES Consortium project, US researchers sequenced 2,726 clinical patient specimens gathered in March 2020 and identified eight unique ORF7a deletion variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Their results are currently available on the bioRxiv* preprint server.

15 Dec 2020

UK government declares identification of a “new variant” of coronavirus

The UK government has released a statement that a “new variant” of coronavirus that could be causing a faster spread of the virus has been identified.

15 Dec 2020

Eureka's InvisiMask human antibody nasal spray offers protection against SARS-CoV-2 in mice

Eureka Therapeutics, Inc. announced today successful preclinical results from its InvisiMask™ Human Antibody Nasal Spray in mice, which offers protection against SARS-CoV-2 S pseudotyped virus infection for up to 10 hours.

14 Dec 2020

£453,000 grant awarded to boost research and development for COVID-19 antibodies

Fusion Antibodies, pre-clinical antibody discovery, engineering and supply experts, and Queen’s University Belfast, leader in innovation and impact, have been awarded a £453,000 grant from Invest Northern Ireland to further expand their COVID-19 targeted research and development efforts.

14 Dec 2020

Virology News and Research

Latest Virology News and Research

NSAIDs dampen antibody and inflammatory responses to SARS-CoV-2 infection in mice

Patients fend for themselves to access highly touted covid antibody treatments

New multidisciplinary center to study origin and course of infectious diseases

On Trump’s last full day, nation records 400,000 covid deaths

National consortium to study the effects of emerging SARS-CoV-2 mutations

Patient with hypertension or cardiovascular diseases experienced critical disease progression with COVID-19

Advanced nanomaterial-based biosensing platform rapidly detects COVID-19 antibodies

Researchers demonstrate lab tool that simplifies simulations of the human intestine

Scientific experts help fight the spread of misinformation about COVID-19 vaccines

Reston virus causes severe respiratory disease in piglets

Scientists map direct interactions between SARS-CoV-2 RNA and human host cells

AOAC INTERNATIONAL issues Certificates of Validation for three test kits that detect SARS-CoV-2

Novel SARS-CoV-2 neutralizing antibody enters Phase 1/2a clinical study

Cell atlas helps better understand the biology of tropical disease parasite

University of Ottawa earns 10 Canada research chairs covering a broad scope of subjects

$3.7 million NIH grant supports development of biosensor technology for diagnosing viral diseases

SARS-CoV-2 unique deletion variants found in clinical specimens

UK government declares identification of a “new variant” of coronavirus

Eureka's InvisiMask human antibody nasal spray offers protection against SARS-CoV-2 in mice

£453,000 grant awarded to boost research and development for COVID-19 antibodies

Microplate-based assays in virology research eBook eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging